Form 4: BiomX Inc. Director Alan Charles Moses Acquires Options
SEC Form 4
Director Alan Charles Moses reports acquisition of options to purchase 17,600 shares of BiomX Inc. common stock.
Summary
- On April 14, 2025, Alan Charles Moses, a director of BiomX Inc., acquired options to purchase 17,600 shares of the company's common stock at an exercise price of $0.538.
- The options vest over four years, with 25% vesting on April 14, 2026, and the remainder vesting in 12 equal quarterly installments over three years.
- Following the transaction, Moses directly owns options for 17,600 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition by a company director.
Industry Context
This is a standard disclosure related to insider transactions, common in the biopharmaceutical industry where stock options are frequently used as part of executive compensation packages.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, reflecting confidence from a director.
Key Dates
| Date | Description |
|---|---|
| 04/14/2025 | Date of the options transaction. |
| 04/14/2026 | 25% of the options vest. |
| 04/14/2035 | Expiration date of the options. |
| 04/18/2025 | Date of signature on the Form 4. |
Keywords
BiomX Inc., Alan Charles Moses, options, director, acquisition, Form 4, PHGE, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.